See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2011_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 646,556,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,100,000 |
| 2 | PropertyPlantAndEquipmentNet | 162,240,000 |
| 3 | remainder_Assets | 159,141,000 |
| 4 | LiabilitiesCurrent | 138,515,000 |
| 5 | LiabilitiesNoncurrent | 9,324,000 |
| 6 | remainder_Liabilities | 4,462,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 227,488,000 |
| 9 | ResearchAndDevelopmentExpense | 98,394,000 |
| 10 | remainder_Expenses | 117,122,000 |
| 11 | remainder_Revenues | 540,957,000 |
| 12 | remainder_NetIncome | -923,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,012,037,000 |
| 1 | Liabilities | 152,301,000 |
| 2 | Expenses | 443,004,000 |
| 3 | Revenues | 540,957,000 |
| 4 | StockholdersEquity | 859,736,000 |
| 5 | NetIncome | 97,030,000 |
| 6 | ComprehensiveNetIncome | 97,030,000 |
| 7 | BaseVar | 1,074,611,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.39 |
| 9 | EconomicCapitalRatio | 3.95 |
Edgar->Model Mapping
Feature Distribution
